Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.775
-0.020 (-2.48%)
Nov 21, 2024, 11:55 AM EST - Market open
Vor Biopharma Employees
Vor Biopharma had 168 employees as of December 31, 2023. The number of employees increased by 35 or 26.32% compared to the previous year.
Employees
168
Change (1Y)
35
Growth (1Y)
26.32%
Revenue / Employee
n/a
Profits / Employee
-$669,423
Market Cap
53.23M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 168 | 35 | 26.32% |
Dec 31, 2022 | 133 | -2 | -1.48% |
Dec 31, 2021 | 135 | 47 | 53.41% |
Dec 31, 2020 | 88 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Singular Genomics Systems | 255 |
Enzo Biochem | 136 |
Vicarious Surgical | 131 |
Precision BioSciences | 109 |
Aadi Bioscience | 89 |
Shattuck Labs | 75 |
Immuneering | 68 |
Kezar Life Sciences | 58 |
VOR News
- 7 weeks ago - Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer - GlobeNewsWire
- 2 months ago - What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - Benzinga
- 2 months ago - New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies - GlobeNewsWire
- 3 months ago - Vor Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 3 months ago - Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 7 months ago - Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors - GlobeNewsWire